Pseudohypoparathyroidism: History of the disease

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue SUPPL. 2, 2006, Pages 627-633

  de Sanctis, Luisa ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; LUTEINIZING HORMONE; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; SOMATOMEDIN C; THYROTROPIN;

ALBRIGHT SYNDROME; ARTICLE; CLINICAL FEATURE; DISEASE CLASSIFICATION; EXON; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENOME IMPRINTING; HORMONE RESISTANCE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PSEUDOHYPOPARATHYROIDISM;

EID: 33745233113     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/jpem.2006.19.s2.627     Document Type: Article

References (58)

1. Albright F, Burnett CH, Smith PH, Parson W. Pseudo-hypoparathyroidism - an example of Seabright-Bantam syndrome. Endocrinology 1942; 30: 922-932.
2. Chase LR, Melson GL, Aurbach GD. Pseudohypoparathyroidism: defective excretion of 3′-5′-AMP in response to parathyroid hormone. J Clin Invest 1969; 48: 1832-1844.
3. sα gene. Proc Natl Acad Sci USA 1988; 85: 2081-2085.
4. Hayward B, Kamiya M, Strain L, Moran V, Campbell R, Hayashizaki Y, Bonthron DT. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA 1998; 95: 10038-10045.
5. Lalande M. Imprints of disease at GNAS1. J Clin Invest 2001; 107: 793-794.
6. Weinstein LS. Editorial: The stimulatory G protein α-subunit gene: mutations and imprinting lead to complex phenotypes. J Clin Endocrinol Metab 2001; 86: 4622-4626.
7. Kehlenbach RH, Matthey J, Huttner WB. XLαs is a new type of G protein. Nature 1994; 372: 804-809.
8. Bastepe M, Gunes Y, Perez-Villamil B, Hunzelman J, Weinstein LS, Juppner H. Receptor-mediated adenylyl-cyclase activation through X1αs, the extra-large variant of the stimulatory G protein α-subunit. Mol Endocrinol 2002; 16: 1912-1919.
9. s protein alpha-subunit and risk of thrombotic and haemorrhagic disorders. Br J Haematol 2004; 125: 621-628.
10. s protein, is significantly longer than suspected, and so is its companion Alex. Proc Natl Acad Sci USA 2004; 101: 8366-8371.
11. Eder S, Leierer J, Klimaschewski L, Wilhelm A, Volknandt W, Laslop A, Fischer-Colbrie R. Secretion and molecular forms of NESP55, a novel genomically imprinted neuroendocrine-specific protein from AtT-20 cells. Neurosignals 2004; 13: 298-307.
12. Jacobsen AM, Ahlman H, Kolby L, Abrahamsson J, Fischer-Colbrie R, Nilsson O. NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumors of the pancreas and adrenal medulla but not in ileal carcinoids. Br J Cancer 2003; 2: 1746-1754.
13. Schipani E, Weinstein LS, Bergwitz C, Iida-Klein A, Kong XF, Stuhrmann M, Kruse K, Whyte MP, Murray T, Schmidtke J. Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 1995; 80: 1611-1621.
14. Juppner H, Schipani E, Bastepe M, Cole DEC, Lawson ML, Mannstadt M, Hendy GN, Plotkin H, Koshiyama H, Koh T, Crawford JD, Olsen BR, Vikkula M. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci USA 1998; 95: 11798-11803.
15. sα. A cause of pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 2001; 1: 165-171.
16. sα deficiency in platelets. Hum Mol Genet 2002; 11: 2741-2750.
17. Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG, Weinstein LS. A GNAS1 imprinting defect in pseudohypoparathyroidism type Ib. J Clin Invest 2000; 106: 1167-1174.
18. Bastepe M, Lane AH, Juppner H. Paternal uniparental isodisomy of chromosome 20q - and the resulting changes in GNAS1 methylation - as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet 2001; 68: 1283-1289.
19. Jan de Beur SJ, Ding C, Germain-Lee E, Cho J, Maret A, Levine MA. Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1. Am J Hum Genet 2003; 73: 314-322.
20. Bastepe M, Pincus JE, Sugimoto T, Tojo K, Kanatani M, Azuma Y, Kruse K, Rosenbloom AL, Koshiyama H, Juppner H. Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet 2001; 10: 1231-1241.
21. Bastepe M, Frolich LF, Hendy GN, Indridason OS, Josse RG, Koshiyama H, Korkko J, Nakamoto JM, Rosenbloom AL, Slyper AH, Sugimoto T, Tsatsoulis A, Crawford JD, Juppner H. Autosomal dominant pseudo-hypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest 2003; 112: 1255-1263.
22. Bastepe M, Frolich LF, Linglart A, Abu-Zahra HS, Tojo K, Ward LM, Juppner H. Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat Genet 2005; 37: 25-27.
23. Miric A, Vechio JD, Levine MA. Heterogeneous mutations in the gene encoding the alpha-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditary osteodystrophy. J Clin Endocrinol Metab 1993; 76: 1560-1568.
24. Aldred MA, Trembath RC. Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat 2000; 16: 183-189.
25. Mantovani G, Romoli R, Weber G, Brunelli V, De Menis E, Beccio S, Beck-Peccoz P, Spada A. Mutational analysis of GNAS1 in patients with pseudohypoparathyroidism; identification of two novel mutations. J Clin Endocrinol Metab 2000; 85: 4243-4248.
26. Ahrens W, Hiort O, Staedt P, Kirschner T, Marschke C, Kruse K. Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 2001; 86: 4630-4634.
27. de Sanctis L, Romagnolo D, Olivero M, Buzi F, Maghnie M, Scire G, Crino A, Baroncelli GI, Salerno M, di Maio S, Cappa M, Grosso S, Rigon F, Lala R, de Sanctis C, Dianzani I. Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism. Pediatr Res 2003; 53: 749-755.
28. s as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci USA 1988; 85: 617-621.
29. Aldred MA, Aftimos S, Hall C, Waters KS, Thakker RV, Trembath RC, Brueton L. Constitutional deletion of chromosome 20q in two patients affected with Albright hereditary osteodystrophy. Am J Med Genet 2002; 113: 167-172.
30. Levine MA, Jap TS, Mauseth RS, Downs RW, Spiegel AM. Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudo-hypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab 1986; 62: 497-502.
31. sα gene mutation. Am J Med Genet 1998; 77: 261-267.
32. Bastepe M, Juppner H. Pseudohypoparathyroidism. New insights into an old disease. Endocrinol Metab Clin North Am 2000; 29: 569-589.
33. Davies SJ, Hughes HE. Imprinting in, Albright's hereditary osteodystrophy. J Med Genet 1993; 30: 101-103.
34. Linglart A, Carel JC, Garabedian M, Le T, Mallet E, Kottler ML. GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. J Clin Endocrinol Metab 2002; 87: 189-197.
35. Levine MA, Downs RW Jr, Singer M, Marx SJ, Aurbach GD, Spiegel AM. Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. Biochem Biophys Res Commun 1980; 94: 1319-1324.
36. Spiegel AM, Levine MA, Marx SJ, Aurbach GD. Pseudohypoparathyroidism: the molecular basis for hormone resistance-a retrospective study. N Engl J Med 1982; 307: 679-681.
37. Bastepe M, Juppner H. GNAS locus and pseudohypoparathyroidism. Horm Res 2005; 63: 65-74.
38. Wilson LC, Hall CM. Albright's hereditary osteodystrophy and pseudohypoparathyroidism. Semin Musculoskelet Radiol 2002; 6: 273-283.
39. de Sanctis L, Vai S, Andreo MR, Romagnolo D, Silvestro L, de Sanctis C. Brachydactyly in 14 genetically characterized pseudohypoparathyroidism type Ia patients. J Clin Endocrinol Metab 2004; 89: 1650-1655.
40. Germain-Lee EL, Groman J, Crane JL, Jan de Beur S, Levine MA. Growth hormone deficiency in pseudohypoparathyroidism type Ia: another manifestation of multihormone resistance. J Clin Endocrinol Metab 2003; 88: 4059-4069.
41. Mantovani G, Maghnie M, Weber G, De Menis E, Brunelli V, Cappa M, Loli P, Beck-Peccoz P, Spada A. Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab 2003; 88: 4070-4074.
42. Bastepe M, Weinstein LS, Ogata N, Kawaguchi H, Juppner H, Kronenberg HM, Chung UI. Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc Natl Acad Sci USA 2004; 101: 14794-14799.
43. sα gene in human bone and adipose tissue. J Clin Endocrinol Metab 2004; 89: 6316-6319.
44. Ahmed SF, Barr DG, Bonthron DT. GNAS1 mutations and progressive osseous heteroplasia. N Engl J Med 2002; 346: 1669-1671.
45. Shore EM, Ahn J, Jan de Beur S, Li M, Xu M, Gardner RJ, Zasloff MA, Whyte MP, Levine MA, Kaplan FS. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med 2002; 346: 99-106.
46. Kutilek S, Kabicek P, Nedvidkova J, Bayer M. Pseudohypoparathyroidism type IA and II with severe neuropsychic manifestations. Turk J Pediatr 2001; 43: 70-75.
47. Levine MA, Downs RW Jr, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM. Resistance to multiple hormones in patients with pseudohypoparathyroidism: association with deficient activity of guanine nucleotide regulatory protein. Am J Med 1983; 74: 545-556.
48. Vlaeminck-Guillem V, d'Herbomez M, Pigny P, Fayard A, Bauters C, Decoulx M, Wemeau JL. Pseudohypoparathyroidism Ia and hypercalcitoninemia. J Clin Endocrinol Metab 2001; 86: 3091-3096.
49. Carlson HE, Brickman AS, Bottazzo GF. Prolactin deficiency in pseudohypoparathyroidism. N Engl J Med 1997; 296: 140-144.
50. sα protein deficiency. J Clin Endocrinol Metab 1997; 82: 247-250.
51. Kidd GS, Schaaf M, Adler RA, Lassman MN, Wray HL. Skeletal responsiveness in pseudohypoparathyroidism. A spectrum of clinical disease. Am J Med 1980; 68: 772-781.
52. Breslau NA, Moses AM, Pak CY. Evidence for bone remodeling but lack of calcium mobilization response to parathyroid hormone in pseudohypoparathyroidism. J Clin Endocrinol Metab 1983; 57: 638-644.
53. Weisman Y, Golancer A, Spirer Z, Farfel Z. Pseudohypoparathyroidism type Ia presenting as congenital hypothyroidism. J Pediatr 1985; 107: 413-415.
54. Riepe FG, Ahrens W, Krone N, Folster-Holst R, Brasch J, Sippell WG, Hiort O, Partsch CJ. Early manifestation of calcinosis cutis in pseudohypoparathyroidism type Ia associated with a novel mutation in the GNAS gene. Eur J Endocrinol 2005; 152: 515-519.
55. Marguet C, Mallet E, Basuyau JP, Martin D, Leroy M, Brunelle P. Clinical and biological heterogeneity in pseudohypoparathyroidism syndrome. Results of a multicenter study. Horm Res 1997; 48: 120-130.
56. Namnoum AB, Merriam GR, Moses AM, Levine MA. Reproductive dysfunction in women with Albright hereditary osteodystrophy. J Clin Endocrinol Metab 1998; 83: 824-829.
57. de Sanctis C, Lala R, Matarazzo P, Andreo M, de Sanctis L. Pubertal development in patients with McCune-Albright syndrome or pseudohypoparathyroidism. J Pediatr Endocrinol Metab 2003; 16 (Suppl 2): 293-296.
58. Jüppner H, Bastepe M. Different mutations within or upstream of the GNAS locus cause distinct forms of pseudohypoparathyroidism. J Pediatr Endocrinol Metab 2006; 19 (Suppl 2): 641-646.